The Expression of Programmed Death-1 in Circulating CD4+ and CD8+ T Cells during Hepatitis B Virus Infection Progression and Its Correlation with Clinical Baseline Characteristics

키워드

참고문헌 (45)

1. Wherry EJ., "T cell exhaustion", Nat Immunol, 12, pp.492~499 (2011)
2. Mueller SN, "High antigen levels are the cause of T cell exhaustion during chronic viral infection", Proc Natl Acad Sci U S A, 106, pp.8623~8628 (2009)
3. Bucks CM, "Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion", J Immunol, 182, pp.6697~6708 (2009)
4. Han S, "Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery", Proc Natl Acad Sci U S A, 107 (2010)
5. Crespo J, "T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment", Curr Opin Immunol, 25, pp.214~221 (2013)
6. Barber DL, "Restoring function in exhausted CD8 T cells during chronic viral infection", Nature, 439, pp.682~687 (2006)
7. Raghuraman S, "Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion", J Infect Dis, 205, pp.763~771 (2012)
8. Berinstein NL, "Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model", Ann N Y Acad Sci, 1174, pp.107~117 (2009)
9. Fourcade J, "CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1", Cancer Res, 72, pp.887~896 (2012)
10. Nebbia G, "Upregulation of the Tim-3", galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection, 2012, pp.7, e47648~
11. Blackburn SD, "Coregulation of CD8+T cell exhaustion by multiple inhibitory receptors during chronic viral infection", Nat Immunol, 10, pp.29~37 (2009)
12. Wherry EJ, "Molecular signature of CD8+T cell exhaustion during chronic viral infection", Immunity, 27, pp.670~684 (2007)
13. Yamamoto T, "Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection", Blood, 117, pp.4805~4815 (2011)
14. Leibson PJ, "The regulation of lymphocyte activation by inhibitory receptors", Curr Opin Immunol, 16, pp.328~336 (2004)
15. Fife BT, "Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways", Immunol Rev, 224, pp.166~182 (2008)
16. Carreno BM, "BTLA: a new inhibitory receptor with a B7-like ligand", Trends Immunol, 24, pp.524~527 (2003)
17. Keir ME, "PD-1 and its ligands in tolerance and immunity", Annu Rev Immunol, 26, pp.677~704 (2008)
18. Alegre ML, "T-cell regulation by CD28 and CTLA-4", Nat Rev Immunol, 1, pp.220~228 (2001)
19. Schurich A, "Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection", Hepatology, 53, pp.1494~1503 (2011)
20. Day CL, "PD-1 expression on HIVspecific T cells is associated with T-cell exhaustion and disease progression", Nature, 443, pp.350~354 (2006)
21. Blank C, "Contribution of the PD-L1", PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion, 2007, pp.56, 739~745
22. Haymaker C, "PD-1 and BTLA and CD8(+) T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint", Oncoimmunology, 1, pp.735~738 (2012)
23. Peng G, "Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients", J Clin Immunol, 31, pp.195~204 (2011)
24. Zhang JY, "PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors", Blood, 109, pp.4671~4678 (2007)
25. Nan XP, "Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection", Viral Immunol, 23, pp.63~70 (2010)
26. Sakuishi K, "Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity", J Exp Med, 207, pp.2187~2194 (2010)
27. Nakamoto N, "Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1", CTLA-4 blockade, 2009, pp.5, e1000313~
28. Kaufmann DE, "PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention", J Immunol, 182, pp.5891~5897 (2009)
29. Jin HT, "Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection", Proc Natl Acad Sci U S A, 107, pp.14733~14738 (2010)
30. Watanabe T, "PD-1", PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection, 2010, pp.17, 453~458
31. Tzeng HT, "PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model", PLoS One, 7, pp.e39179~ (2012)
32. Fisicaro P, "Antiviral intrahepatic Tcell responses can be restored by blocking programmed death-1pathway in chronic hepatitis B", Gastroenterology, 138, pp.682~693 (2010)
33. Okazaki T, "New regulatory co-receptors: inducible co-stimulator and PD-1", Curr Opin Immunol, 14, pp.779~782 (2002)
34. Sharpe AH, "The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection", Nat Immunol, 8, pp.239~245 (2007)
35. Gehring AJ, "Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma", Gastroenterology, 137, pp.682~690 (2009)
36. Golden-Mason L, "Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction", J Virol, 81, pp.9249~9258 (2007)
37. Norris S, "PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection", Viral Immunol, 25, pp.329~332 (2012)
38. Zhou Q, "Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia", Blood, 117, pp.4501~4510 (2011)
39. Albers I, "Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis", Scand J Gastroenterol, 24, pp.269~276 (1989)
40. Llovet JM, "Prognosis of hepatocellular carcinoma:the BCLC staging classification", Semin Liver Dis, 19, pp.329~338 (1999)
41. Sedy JR, "B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator", Nat Immunol, 6, pp.90~98 (2005)
42. Liang XS, "Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells", World J Gastroenterol, 16, pp.618~624 (2010)
43. Moorman JP, "Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses", Vaccine, 29, pp.3169~3176 (2011)
44. Ye P, "Programmed death-1 expression is associated with the disease status in hepatitis B virus infection", World J Gastroenterol, 14, pp.4551~4557 (2008)
45. Zeng Z, "Upregulation of circulating PDL1", PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma, 2011, pp.6, e23621~

관련 논문AI추천